Australian Clinical Labs
ACL.AX
#7734
Rank
โ‚น41.18 B
Marketcap
โ‚น220.79
Share price
0.00%
Change (1 day)
42.34%
Change (1 year)

P/S ratio for Australian Clinical Labs (ACL.AX)

P/S ratio at the end of 2026: 0.5666

According to Australian Clinical Labs's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.24. At the end of 2026 the company had a P/S ratio of 0.5666.

P/S ratio history for Australian Clinical Labs from 2021 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20260.5666-23.51%
20250.74071.51%
20240.7297-27.27%
20231.007.66%
20220.9318-13.13%
20211.07